Physician

Robert Marquinez, M.D.

According to 2025 Medicare claims, Robert Marquinez, M.D. (NPI: 1407910714) practices internal medicine in the Eagle Pass, TX market, with the plurality of this provider's patient population coming from Maverick, TX. This provider's primary affiliated billing organization is UNITED MEDICAL CENTERS (NPI: 1710980669; TIN: 741993570) and primary practice location at 78852-5148. Marquinez is affiliated with the TACHC Accountable Care Organization LLC (ACO ID: A5562), participating under the MSSP model.

Marquinez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 36 traditional Medicare patients, billed 104 HCPCS/CPT codes, and received $5,416 in Medicare payments. Part D data shows 15,160 prescription claims across 871 beneficiaries totaling $2,758,844 in drug costs, led by Ozempic (Semaglutide). DME data shows 102 claims. Open Payments data shows 31 records totaling $594. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $15,475 to $5,416. In contrast, Part D prescription costs have risen steadily, from $1,679,364 to $2,758,844. For DME billing, reported payments moved from a higher plateau to a lower plateau, from $23,822 to $9,243.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	118	417	$15,475
2016	123	466	$14,833
2017	170	706	$28,812
2018	164	534	$20,957
2019	138	456	$19,109
2020	77	269	$9,569
2021	198	401	$13,373
2022	133	303	$9,491
2023	46	115	$4,728
2024	36	104	$5,416

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	829	15,776	$1,679,364
2016	839	14,267	$1,750,439
2017	835	12,760	$1,780,064
2018	849	13,830	$2,096,581
2019	857	14,253	$2,421,783
2020	850	14,649	$2,477,347
2021	854	14,088	$2,487,343
2022	879	14,574	$2,860,255
2023	895	14,771	$3,128,170
2024	871	15,160	$2,758,844

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	362	1,020	$35,251
2016	332	991	$24,029
2017	262	694	$19,783
2018	305	884	$20,864
2019	252	760	$17,566
2020	108	483	$11,481
2021	105	351	$6,879
2022	79	275	$10,162
2023	45	156	$9,538
2024	24	102	$7,403

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	292	14,184	$475,256
Farxiga	Dapagliflozin Propanediol	220	16,488	$311,420
Linzess	Linaclotide	160	13,935	$254,084
Januvia	Sitagliptin Phosphate	124	10,390	$196,991
Jardiance	Empagliflozin	104	7,395	$148,945

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$6,372
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	31	$566
K0001	Standard wheelchair	Y	N/R	16	$238
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	17	$189
A4259	Lancets, per box of 100	N	11	23	$38

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$594	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Marquinez, M.D.?

Tedicare shows public-source Medicare data for Robert Marquinez, M.D. (NPI 1407910714), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Marquinez, M.D. have ACO affiliation data?

Robert Marquinez, M.D. is shown with ACO affiliation data for TACHC Accountable Care Organization LLC (MSSP, ACO ID A5562).

What billing organization is linked to Robert Marquinez, M.D.?

Robert Marquinez, M.D. is linked to UNITED MEDICAL CENTERS (billing NPI 1710980669) in the available physician profile data.

Does Robert Marquinez, M.D. have Open Payments data?

Robert Marquinez, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.